Tandem Diabetes Care Prices Initial Public Offering
November 13, 2013Tandem Diabetes Care, a medical device company and manufacturer of the t:slim® Insulin Pump, announced the pricing of its IPO of 8,000,000 shares of common stock at $15 per share and will trade on the NASDAQ Global Market under the ticker symbol "TNDM."
More »
Esperion Therapeutics Announces Oral Presentation on ETC-1002 at 2013 Scientific Sessions of the American Heart Association
November 11, 2013Esperion Therapeutics Announces Oral Presentation on ETC-1002 at 2013 Scientific Sessions of the American Heart Association
More »
Afferent Pharmaceuticals Names Michael M. Kitt, M.D., as Chief Medical Officer
November 6, 2013Dr. Kitt most recently served as SVP Clinical Research & Regulatory Affairs and CMO at Portola Pharmacueticals. Afferent also appointed Kathleen Sereda Glaub to the Company’s board of directors.
More »